CTKB
Cytek Biosciences Inc price
-5.07% Past Week
Market Cap
716.71M
Day’s Range
52W Range
Volume (3M)
666.87K
Price-Earnings Ratio
-41.35
Revenue
197.71M
Top Discussions
7
MAY
Reports
Q1, 2024 earnings report expected
CTKB
Cytek Biosciences Inc
5.45
0.15
(2.83%)
7
MAY
Reports
Q1, 2024 earnings report expected
CTKB
Cytek Biosciences Inc
5.45
0.15
(2.83%)
28
FEB
Reports
Q4, 2023 earnings report expected
CTKB
Cytek Biosciences Inc
5.45
0.15
(2.83%)
27
FEB
Reports
Q4, 2023 earnings report expected
CTKB
Cytek Biosciences Inc
5.45
0.15
(2.83%)
7
NOV
Reports
Q3, 2023 earnings report expected
CTKB
Cytek Biosciences Inc
5.45
0.15
(2.83%)
About Cytek Biosciences Inc
Cytek Biosciences Inc is an American biotechnology company engaged in the manufacture and supply of flow cytometry products and services including Full Spectrum Profiling technology and a range of reagent testing solutions. The firm was founded in 1992 and is based in San Francisco, California.
The firm is eager to accelerate the adoption of flow cytometry solutions in order to support scientific discovery and offers a range of affordable instruments and support options which are now used by clinicians and researchers worldwide. Cytek is listed on the NASDAQ and trades under the ticker CTKB.
Diversify your investments by adding CTKB stock to your eToro portfolio.
Show MoreWen Bin Jiang, PhD
CEO
676
Employees
1992
Founded
Fremont, California, US
HQ
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
45
Low
Industry
Avg. 49
31
Environment
50
Social
41
Governance
People Also Bought
RPAY Repay Holdings Corp -0.62% 
ENTA Enanta Pharmaceuticals Inc 0.78% 
GNLX Genelux Corporation -5.34% 
YMAB Y-mAbs Therapeutics Inc -3.18%